ReviewClinical pharmacology and therapeutics2018

Considerations for Developing Targeted Therapies in Low-Frequency Molecular Subsets of a Disease.

Robert N Schuck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.